Quin Wills,
Research Fellow
Being trained in clinical medicine, molecular genetics and the quantitative sciences (computational biology, mathematics
and statistics), I have held a long-standing interest in precision medicine. Starting with the VC funded drug
screening company I founded, followed by my NIH funded pharmacogenomics postdoctoral year at the
Mayo Clinic Center for Individualized Medicine, and now more recently with my return to Oxford to help develop single-cell methods as part of the University's new Single Cell Biology Consortium.
|
|
|
